Adults between 18 and 65 years of age with moderate to severe alopecia areata (hair loss), may qualify to participate. Individuals must have 50% or more hair loss of the scalp, with a history of recurrence and spontaneous remission. Must have a current episode of hair loss lasting at least 6 months and not exceeding 10 years. Total disease duration greater than 10 years is permitted. Must not have a history or presence of hair transplants.
Participants will receive investigational oral medication (active study drug) in one of two doses. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.
Study participation will last about 32 weeks and involve about 11 visits to the study centre.
Email Tina Craig, Clinical Research Coordinator at DermEffects to register.